• Fund Type: ETF
  • Objective: Health Care
  • Asset Class: Equity
  • Geographic Focus: U.S.

iShares Nasdaq Biotechnology ETF

+ Add to Watchlist

IBB:US

253.6800 USD 2.8200 1.12%

As of 17:20:00 ET on 07/22/2014.

Snapshot for iShares Nasdaq Biotechnology ETF (IBB)

Open: 252.2700 High - Low: 254.8800 - 252.2700 Primary Exchange: NASDAQ GM
Volume: 1,184,770 52-Week Range: 187.0500 - 275.4000 Beta vs XNBI: 1.0036

ETF Chart for IBB

No chart data available.
  • IBB:US 253.5100
  • 1D
  • 1M
  • 1Y
250.8600
Interactive IBB Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Fund Profile & Information for IBB

iShares Nasdaq Biotechnology ETF is an exchange-traded fund incorporated in the USA. The Fund's objective seeks investment results that correspond to the performance of the Nasdaq Biotechnology Index. The Fund will concentrate its investments in companies primarily engaged in using biomedical research for the discovery or development of new treatments or cures for human disease.

Inception Date: 2001-02-09 Telephone: 1-415-670-2000
Managers: GREG SAVAGE
Web Site: www.ishares.com

Fundamentals for IBB

NAV (on 2014-07-21) 250.8200
Assets (M) (on 2014-07-21) 4,991.2640
Shares out (M) 19.90
Market Cap (M) 5,026.74
% Premium 0.02
Average 52-Week % Premium -0.0008
Fund Leveraged N

Dividends for IBB

Dividend Type Income
Dividend Frequency Quarter
Last Dividend Net -
Dividend Yield (ttm) 0.16%

Performance for IBB

1-Month -1.72% 1-Year +28.84%
3-Month +10.52% 3-Year +32.45%
Year To Date +10.65% 5-Year +28.21%
Expense Ratio 0.48

Top Fund Holdings for IBB

Filing Date: 07/17/2014
Name Position Value % of Total
Celgene Corp 4,774,736 396,923,804 8.547%
Gilead Sciences Inc 4,498,746 382,708,322 8.241%
Amgen Inc 3,149,784 363,453,576 7.827%
Biogen Idec Inc 1,143,944 342,371,000 7.373%
Alexion Pharmaceuticals Inc 2,007,997 311,360,015 6.705%
Vertex Pharmaceuticals Inc 2,527,982 238,869,019 5.144%
Illumina Inc 1,154,321 191,801,977 4.130%
Mylan Inc/PA 3,665,165 188,499,436 4.059%
Regeneron Pharmaceuticals Inc 595,098 176,392,998 3.798%
Endo International PLC 1,664,950 109,919,999 2.367%

Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil